EMD-47305

Single-particle
3.03 Å
EMD-47305
3D View Gallery
Deposition: 14/10/2024
Map released: 15/01/2025
Last modified: 15/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-47305

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9dyi summary report (pdf.gz) Map-9dyi FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BEST2 + glutamate closed state

EMD-47305

Single-particle
3.03 Å
EMD-47305
3D View Gallery
Deposition: 14/10/2024
Map released: 15/01/2025
Last modified: 15/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: BEST2 + glutamate closed state
Fitted models: 9dyi

Deposition Authors: Owji AP, Kittredge A , Zhang Y , Yang T
Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment.
Owji AP, Dong J, Kittredge A , Wang J , Zhang Y , Yang T
(2024) Nat Commun , 15 , 10766 - 10766
PUBMED: 39737942
DOI: doi:10.1038/s41467-024-54938-z
ISSN: 2041-1723